Molecular pharmacology of serotonin-gated chloride channel
; Bouzat, Cecilia Beatriz
; Corradi, Jeremias 
Otros responsables
Fecha
2018
Editorial
Sociedad argentina de investigación en biofísica
Revista
Título del libro
Nombre del evento
XLVII Reunión Anual de la Sociedad Argentina de Biofísica
Fecha del evento
2018-12-05
Institución organizadora
Sociedad Argentina de Investigación en Biofísica
ISSN
eISSN
ISBN
978-987-27591-6-2
Idioma
Español
Tipo del evento
Congreso
Clasificación temática
Resumen
Serotonin-gated ion channels (5-HT3) belong to the family of Cys-loop receptors, which are pentameric proteins that mediate fast synaptic transmission. In mammals, 5-HT3 receptors are non-selective cation channels that can be found as homomers (5-HT3A) or heteromers when combined with 5HT3B-E subunits. The free-leaving nematode Caenorhabditis elegans is a model for the study of the nervous system and human diseases, and for antiparasitic drug discovery. C. elegans contains a homomeric serotonin-gated Cys-loop receptor, MOD-1, that is permeable to chloride. We here expressed MOD-1 in mammalian cells and explored the properties of activation and modulation of MOD-1 by whole cell recordings. Dose-response curves showed an EC50 for 5-HT of ~1 mM, which is in the same range as that of human 5-HT3A receptors. The analysis showed that currents do not show rectification, desensitize slowly and recover from desensitization with a time constant of about 1 s. To characterize the pharmacology of MOD-1, we tested compounds that have been shown to modulate 5-HT3 and other Cys-loop receptors. The antiparasitic drug ivermectin (IVM), which acts as an activator or modulator of different receptors, neither activated nor potentiated MOD-1. However, pre-exposure to IVM (10-50 mM) decreased 5-HT induced currents, indicating that it acts as an inhibitor of MOD-1. The 5-HT3 receptor potentiator, 5-hydroxyindol, did not affect MOD-1 function, whereas thymol, which is an activator and/or modulator of 5-HT3 receptors, could only modulate MOD-1 activity. These results contribute to the understanding of the molecular pharmacology of MOD-1 as a potential drug target for anthelmintic therapy
Colecciones
Aprobación
Revisión
Complementado por
Referenciado por
Licencia Creative Commons
Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa
